Daily Stock Analysis, VYM, VOYAGER THERAPEUTICS INC, priceseries

VOYAGER THERAPEUTICS INC. Daily Stock Analysis
Stock Information
Open
110.16
Close
108.79
High
110.38
Low
108.61
Previous Close
110.66
Daily Price Gain
-1.87
YTD High
115.66
YTD High Date
Jan 13, 2022
YTD Low
104.95
YTD Low Date
Feb 24, 2022
YTD Price Change
-3.85
YTD Gain
-3.42%
52 Week High
115.66
52 Week High Date
Jan 13, 2022
52 Week Low
95.37
52 Week Low Date
Mar 8, 2021
52 Week Price Change
12.72
52 Week Gain
13.24%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Nov 28. 2017
73.33
Jan 30. 2018
78.41
42 Trading Days
6.92%
Link
LONG
Jan 4. 2019
71.65
Mar 6. 2019
77.45
41 Trading Days
8.10%
Link
Company Information
Stock Symbol
VYM
Exchange
NASDAQ
Company URL
http://www.voyagertherapeutics.com
Company Phone
857-259-5340
CEO
Steven Marc Paul
Headquarters
Massachusetts
Business Address
75 SIDNEY STREET, CAMBRIDGE, MA 02139
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001640266
About

Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops gene therapies for fatal and debilitating diseases of the central nervous system. It focuses in the field of adeno-associated virus gene therapy through innovation and investment in vector optimization and engineering, and dosing techniques, as well as process development and production. The company was founded by Guangping Gao, Mark A. Kay, Krystof Bankiewicz and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.

Description

Gene therapy biotech targeting Parkinson's disease and other CNS disorders.